Parameter | Supplements | Placebo | Interventions | |
---|---|---|---|---|
4 weeks | 8 weeks | |||
Plasma 1,25-(OH)2D [pmol/l] | CaPt | 102.9a (24.7) | 93.3b (24.7) | 76.3c (24.5) |
Vitamin D3 t | 97.9 (27.5) | 108.3 (23.9) | 99.2 (38.1) | |
CaP+vitamin D3 t | 92.2b (31.0) | 100.4a (31.1) | 86.0b (23.1) | |
Plasma osteocalcin [ng/ml] | CaP | 20.3 (6.5) | 20.4 (6.5) | 20.9 (7.2) |
Vitamin D3 | 21.8 (7.2) | 23.4 (8.2) | 20.7 (8.8) | |
CaP+vitamin D3 | 20.1 (7.0) | 20.2 (6.4) | 19.9 (7.6) | |
Plasma alkaline phosphatase | CaP | 9.6a (3.9) | 10.7b (3.9) | 9.3a (3.7) |
Vitamin D3 | 9.1a (3.5) | 10.3b (3.6) | 9.0a (3.6) | |
CaP+vitamin D3 | 9.8a (3.4) | 11.3b (3.9) | 9.5a (3.1) | |
Serum PTH [μg/l] | CaP | 56.6 (12.2) | 74.4 (35.8) | 71.9 (25.1) |
Vitamin D3 | 65.0 (24.7) | 71.2 (29.2) | 66.5 (21.0) | |
CaP+vitamin D3 | 62.0 (20.1) | 63.3 (17.8) | 60.6 (19.8) | |
Serum CTX [ng/ml] | CaP | 0.3 (0.1) | 0.2 (0.1) | 0.3 (0.2) |
Vitamin D3 | 0.3 (0.2) | 0.3 (0.2) | 0.3 (0.1) | |
CaP+vitamin D3 | 0.3 (0.1) | 0.2 (0.1) | 0.2 (0.1) | |
Serum P1NP [ng/ml] | CaP | 44.5 (19.1) | 42.5 (16.5) | 44.2 (19.7) |
Vitamin D3 | 48.8 (18.9) | 44.4 (20.7) | 50.9 (24.7) | |
CaP+vitamin D3 | 41.4 (17.6) | 36.3 (19.7) | 40.4 (15.9) | |
Urine DPD [nmol/l] | CaP | 29.2 (14.9) | 31.6 (20.0) | 27.0 (14.5) |
Vitamin D3 | 25.3 (13.7) | 22.8 (11.5) | 25.5 (9.8) | |
CaP+vitamin D3 | 23.7 (9.0) | 25.8 (16.0) | 28.1 (15.2) | |
Urine CTX [mg/l] | CaP | 1.0 (0.6) | 1.1 (1.1) | 0.7 (0.5) |
Vitamin D3 | 0.9 (0.7) | 0.8 (0.6) | 1.1 (0.6) | |
CaP+vitamin D3 | 0.9 (0.7) | 0.9 (0.7) | 1.2 (1.1) |